BREFELDIN-A REVERSIBLY BLOCKS EARLY BUT NOT LATE PROTEIN-TRANSPORT STEPS IN THE YEAST SECRETORY PATHWAY

We have found that brefeldin A (BFA) inhibited the growth of an ise1 mutant of Saccharomyces cerevisiae. Genetic complementation and mapping studies demonstrated that ise1 was allelic to erg6, a gene required for the biosynthesis of the principal membrane sterol of yeast, ergosterol. Treatment of ise1 cells with BFA resulted in an immediate block in protein transport through the secretory pathway. Vacuolar carboxypeptidase Y (CPY) and the secreted pheromone alpha-factor accumulated as both the core glycosylated (ER) and alpha1,6 mannosylated (early Golgi) forms in drug-treated cells. The modification of alpha-factor with alpha1,6 mannose in BFA-treated cells did not appear to result from retrograde transport of the alpha1,6 mannosyltransferase into the ER. We found that transport of CPY from medial and late Golgi compartments to the vacuole was unaffected by BFA, nor was secretion of alpha1,3 mannosylated alpha-factor or invertase blocked by BFA. The effects of BFA on the secretory pathway were also reversible after brief exposure (< 40 min) to the drug. We suggest that the primary effect of BFA in S.cerevisiae is restricted to the ER and the alpha1.6 mannosyltransferase compartment of the Golgi complex.